Fresh analysis indicates that individuals who come off new slimming jabs like Wegovy and Mounjaro tend to recover shed pounds at a significantly accelerated pace than those who halt conventional lifestyle regimens.
Published data in a major medical journal points out that while overweight individuals often shed substantial amounts of their body weight while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month after stopping.
"Users buying these medications need to be cognizant of the potential of quick rebound weight gain when the therapy concludes," stated expert Dr. Susan Jebb.
That rate of recovery suggests a return to starting weight within about one and a half years.
Comparing Treatments
The research, which looked at dozens of studies involving thousands of patients, contrasted the results of the injectable medications with other pills.
The team note that individuals who shed pounds through lifestyle changes alone usually have a less rapid creep back—perhaps 0.1 kg a month—after stopping.
Understanding the Rapid Rebound
Experts propose the way of the jabs accounts for the accelerated regain.
The injections mimic a body's own chemical called glucagon-like peptide-1, which moderates appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal may cause the body to generate a reduced amount of its own natural hormone, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Discontinuation of this GLP-1 'fix' results in appetite is no longer kept in check, making excessive eating much more probable."
A Chronic Disease?
Medical guidelines suggest the injections for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians contend that, given the high risk of relapse, the therapy might need to be ongoing.
This opinion is echoed by drug manufacturers, who state that the findings "highlight the long-term character of excess weight," comparing it to managing conditions like diabetes.
Patient Accounts
People who have discontinued the jabs report a intense resurgence of appetite.
"I experienced something that goes on and you're instantly extremely hungry," said one woman.
The struggle is worsened if users have not adopted permanent dietary or behavioural modifications during therapy.
Widespread Use
Figures indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Adoption is more common among females than men.
- The middle-aged demographic shows the greatest level of interest.
- Many obtain the medications through private prescriptions rather than the NHS.
Ultimately, experts emphasize that while the jabs are powerful agents for shedding pounds, they are not a magic fix and long-term success likely depends on integrated behavioural management.
